ImmuCell financial statements

이뮤셀NASDAQ:ICCC · Nasdaq · Healthcare · sector #16
$9.97+2.26%
2026-10-06 close · prelim

ImmuCell's published financial data is dated 2026-10-04. 2024 revenue was $26M. 2024 operating profit was −$2M.

Reported results

ImmuCell notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q